VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation

被引：0
|
作者：
Kleinschmidt-DeMasters, Bette [1 ]
Foreman, Nicholas [2 ]
Lummus, Seth [3 ]
机构：
[1] Univ Colorado Anschutz Med Campus, Denver, CO USA
[2] Childrens Hosp Colorado, Aurora, CO USA
[3] Univ Colorado, Dept Pathol, Boulder, CO 80309 USA
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2014年 / 73卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
175
引用
收藏
页码：631 / 632
页数：2
相关论文
共 50 条
  • [21] VE1 Antibody Immunoreactivity in Normal Anterior Pituitary and Adrenal Cortex Without Detectable BRAF V600E Mutations
    Mordes, Daniel A.
    Lynch, Kerry
    Campbell, Sharon
    Dias-Santagata, Dora
    Nose, Vania
    Louis, David N.
    Hoang, Mai P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (06) : 811 - 815
  • [22] VE1 Antibody Is Not Highly Specific for the BRAF V600E Mutation in Thyroid Cytology Categories With the Exception of Malignant Cases
    Lee, Sang-Ryung
    Yim, Hyunee
    Han, Jae Ho
    Lee, Kyi Beom
    Lee, Jeonghun
    Soh, Euy Young
    Kim, Dae Jung
    Chung, Yoon-Sok
    Jeong, Seon-Yong
    Sheen, Seung Soo
    Park, So Hyun
    Kim, Jang-Hee
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (03) : 437 - 444
  • [23] Assessment of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in benign and malignant salivary gland neoplasms
    Bodnar, Magdalena
    Burduk, Pawel
    Antosik, Paulina
    Jarmuz-Szymczak, Malgorzata
    Wierzbicka, Malgorzata
    Marszalek, Andrzej
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2017, 46 (05) : 340 - 345
  • [24] SENSITIVITY OF IMMUNOHISTOCHEMISTRY WITH BRAF VE1 ANTIBODY FOR BRAF V600E IN PRIMARY CENTRAL NERVOUS SYSTEM TUMORS
    Blaquier, Juan
    Egea, Sophie
    Gultekin, Sakir
    D'Angelo, Fulvio
    Iavarone, Antonio
    de la Fuente, Macarena
    NEURO-ONCOLOGY, 2024, 26
  • [25] Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation
    Ishi, Yukitomo
    Yamaguchi, Shigeru
    Okamoto, Michinari
    Sawaya, Ryosuke
    Endo, Shogo
    Motegi, Hiroaki
    Terasaka, Shunsuke
    Tanei, Zen-ichi
    Hatanaka, Kanako C.
    Tanaka, Shinya
    Fujimura, Miki
    BRAIN TUMOR PATHOLOGY, 2022, 39 (03) : 162 - 170
  • [26] Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation
    Yukitomo Ishi
    Shigeru Yamaguchi
    Michinari Okamoto
    Ryosuke Sawaya
    Shogo Endo
    Hiroaki Motegi
    Shunsuke Terasaka
    Zen-ichi Tanei
    Kanako C. Hatanaka
    Shinya Tanaka
    Miki Fujimura
    Brain Tumor Pathology, 2022, 39 : 162 - 170
  • [27] Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers
    Sadlecki, Pawel
    Walentowicz, Pawel
    Bodnar, Magdalena
    Marszalek, Andrzej
    Grabiec, Marek
    Walentowicz-Sadlecka, Malgorzata
    TUMOR BIOLOGY, 2017, 39 (05)
  • [28] Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
    Ceccon, Garry
    Werner, Jan-Michael
    Dunkl, Veronika
    Tscherpel, Caroline
    Stoffels, Gabriele
    Brunn, Anna
    Deckert, Martina
    Fink, Gereon R.
    Galldiks, Norbert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [29] Transformation of ganglioglioma to epithelioid glioblastoma, both with BRAF V600E mutation
    Lau, Stephanie
    Clark, Jonathan
    Lokan, Julie
    PATHOLOGY, 2022, 54 (05) : 645 - 647
  • [30] Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
    Kleinschmidt-DeMasters, Bette Kay
    Aisner, Dara L.
    Birks, Diane K.
    Foreman, Nicholas K.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (05) : 685 - 698
12345